"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
| Descriptor ID |
D009367
|
| MeSH Number(s) |
E01.789.625
|
| Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 11 | 11 |
| 1997 | 1 | 16 | 17 |
| 1998 | 1 | 17 | 18 |
| 1999 | 2 | 15 | 17 |
| 2000 | 0 | 31 | 31 |
| 2001 | 1 | 20 | 21 |
| 2002 | 0 | 13 | 13 |
| 2003 | 2 | 22 | 24 |
| 2004 | 2 | 17 | 19 |
| 2005 | 2 | 32 | 34 |
| 2006 | 0 | 32 | 32 |
| 2007 | 2 | 46 | 48 |
| 2008 | 2 | 56 | 58 |
| 2009 | 1 | 42 | 43 |
| 2010 | 2 | 62 | 64 |
| 2011 | 4 | 52 | 56 |
| 2012 | 2 | 57 | 59 |
| 2013 | 4 | 62 | 66 |
| 2014 | 4 | 77 | 81 |
| 2015 | 2 | 72 | 74 |
| 2016 | 11 | 58 | 69 |
| 2017 | 5 | 68 | 73 |
| 2018 | 5 | 57 | 62 |
| 2019 | 11 | 57 | 68 |
| 2020 | 2 | 47 | 49 |
| 2021 | 1 | 41 | 42 |
| 2022 | 0 | 25 | 25 |
| 2023 | 1 | 26 | 27 |
| 2024 | 16 | 35 | 51 |
| 2025 | 0 | 28 | 28 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Neighborhood-Level Social Vulnerability, Race and Ethnicity, and Stage at Diagnosis: A Population-Based Study of 12,957 Patients with Oral Cavity Cancer. Cancer Epidemiol Biomarkers Prev. 2026 Mar 02; 35(3):398-405.
-
Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center. Gynecol Oncol. 2025 Oct; 201:203-209.
-
Procedure Patterns and Survival in Advanced Non-Small Cell Lung Cancer With Malignant Airway Obstruction: A Surveillance, Epidemiology, and End Results Medicare Analysis. Chest. 2026 Feb; 169(2):538-549.
-
Durvalumab Plus Platinum-Etoposide in Extensive-Stage Small-Cell Lung Cancer: Outcomes in Age, Sex, and Platinum Subgroups From the Phase 3 CASPIAN Study. Clin Lung Cancer. 2025 Dec; 26(8):626-641.
-
Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary Pathologists. Am J Surg Pathol. 2025 Dec 01; 49(12):1307-1314.
-
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial. Ann Surg Oncol. 2025 Oct; 32(11):8211-8219.
-
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study Results. Clin Lung Cancer. 2025 Nov; 26(7):541-551.
-
Surgical and Perioperative Advances for Patients With Locally Advanced Non-Small Cell Lung Cancer. Am Soc Clin Oncol Educ Book. 2025 Jun; 45(3):e481060.
-
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial. Nat Med. 2025 Jul; 31(7):2397-2404.
-
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study. Future Oncol. 2025 May; 21(12):1511-1523.